Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-adamantanyl-N'-geranyl-ethylenediamine

EU orphan designation number: EU/3/07/479   
Active ingredient: N-adamantanyl-N'-geranyl-ethylenediamine
Indication: Treatment of tuberculosis
Sponsor: RLM Consulting
Chemin du Cyclotron 6, B-1348 Louvain-la-Neuve, Belgique

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/09/2007 Centralised Orphan - Designation EMEA/OD/036/07 (2007)4330 of 14/09/2007